Pass the NRNP 6552 Week 6 Midterm Exam on your first attempt with this complete 2026 updated guide for Advanced Reproductive Health Care at Walden University. This A+ Graded resource contains 100 questions and verified answers covering all key content areas for the Week 6 midterm exam including female reproductive anatomy and physiology (ovarian cycle, menstrual cycle phases (follicular, ovulatory, luteal), hormonal regulation (estrogen, progesterone, FSH, LH, GnRH)), male reproductive anatomy and physiology (spermatogenesis, hormonal control, erectile function), preconception counseling (risk assessment, genetic screening, folic acid supplementation, lifestyle modifications), contraception comprehensive management (combined oral contraceptives (monophasic, multiphasic), progestin-only pills, transdermal patch, vaginal ring (NuvaRing, Annovera), depot medroxyprogesterone acetate (DMPA/Depo-Provera), etonogestrel implant (Nexplanon), copper IUD (Paragard), levonorgestrel IUDs (Mirena, Kyleena, Liletta, Skyla), barrier methods (external/internal condoms, diaphragm, cervical cap, contraceptive sponge), spermicides, fertility awareness-based methods (standard days method, basal body temperature, cervical mucus monitoring, symptothermal method), lactational amenorrhea method (LAM), emergency contraception (ulipristal acetate (Ella), levonorgestrel (Plan B One-Step, Take Action), copper IUD for emergency contraception), and permanent sterilization (tubal ligation, bilateral salpingectomy, hysteroscopic sterilization (Essure discontinued), vasectomy), infertility evaluation and management (female factor (ovulatory disorders, tubal factor, uterine factor, cervical factor, endometriosis), male factor (semen analysis abnormalities, varicocele, hormonal disorders), diagnostic testing (ovulation assessment (LH surge, progesterone level), ovarian reserve testing (FSH, estradiol, AMH, antral follicle count), hysterosalpingography (HSG), sonohysterography, hysteroscopy, laparoscopy, semen analysis (WHO criteria), treatment options (ovulation induction (clomiphene citrate, letrozole, gonadotropins), intrauterine insemination (IUI), in vitro fertilization (IVF), intracytoplasmic sperm injection (ICSI), donor gametes, surrogacy), sexually transmitted infections (STIs) comprehensive screening (USPSTF guidelines), diagnosis, and management (chlamydia trachomatis (azithromycin, doxycycline), neisseria gonorrhoeae (ceftriaxone plus azithromycin/doxycycline), treponema pallidum (syphilis) (benzathine penicillin G, doxycycline for late latent), herpes simplex virus (HSV-1, HSV-2) (acyclovir, valacyclovir, famciclovir for episodic or suppressive therapy), human papillomavirus (HPV) (vaccination (Gardasil 9), management of anogenital warts (patient-applied (podofilox, imiquimod, sinecatechins) and provider-administered (cryotherapy, TCA, surgical removal)), human immunodeficiency virus (HIV) (PrEP (Truvada, Descovy), PEP, ART, perinatal transmission prevention), trichomonas vaginalis (metronidazole, tinidazole), mycoplasma genitalium (azithromycin, moxifloxacin), bacterial vaginosis (metronidazole, clindamycin, tinidazole), vulvovaginal candidiasis (azoles (miconazole, clotrimazole, fluconazole) for uncomplicated and complicated infections), pelvic inflammatory disease (PID) (CDC outpatient (ceftriaxone plus doxycycline with or without metronidazole) and inpatient regimens), vulvovaginal conditions (lichen sclerosus (ultrapotent topical corticosteroids), lichen planus (topical corticosteroids, tacrolimus), vulvodynia (multidisciplinary approach (cognitive behavioral therapy, pelvic floor physical therapy, topical lidocaine, tricyclic antidepressants, SNRIs, gabapentin/pregabalin)), vaginismus (pelvic floor physical therapy, dilators, botulinum toxin), breast health (clinical breast exam technique, breast self-awareness, mammography screening guidelines (ACR, ACOG, USPSTF), evaluation of breast masses (diagnostic mammogram, breast ultrasound, core needle biopsy, fine needle aspiration, MRI), breast pain (mastalgia) evaluation and management, nipple discharge evaluation (galactorrhea workup, pathologic discharge workup), benign breast conditions (fibrocystic changes (cyclic mastalgia management), fibroadenomas (observation, cryoablation, surgical excision), cysts (simple vs complex management), intraductal papilloma), cervical cancer prevention and screening (HPV vaccination (age recommendations, catch-up vaccination, shared clinical decision-making), Pap smear (LBC, conventional) preparation, collection technique, interpretation (Bethesda system: NILM, ASC-US, LSIL, ASC-H, HSIL, AGC, carcinoma), HPV testing (primary HPV screening, co-testing), colposcopy indications, technique, and findings (acetowhite epithelium, punctation, mosaicism, atypical vessels), cervical intraepithelial neoplasia (CIN) management (CIN 1 observation, CIN 2/3 treatment (LEEP, CKC, ablation)), abnormal uterine bleeding (AUB) evaluation (history, physical exam, labs (CBC, TSH, prolactin, FSH, pregnancy test), imaging (transvaginal ultrasound, saline infusion sonography, MRI), PALM-COEIN classification system (Polyp, Adenomyosis, Leiomyoma, Malignancy/hyperplasia, Coagulopathy, Ovulatory dysfunction, Endometrial, Iatrogenic, Not yet classified), polycystic ovary syndrome (PCOS) diagnosis (Rotterdam criteria (2 of 3: oligo/anovulation, clinical/biochemical hyperandrogenism, polycystic ovaries on ultrasound)), management (lifestyle modification (diet, exercise, weight loss), hormonal contraceptives for cycle regulation and androgen blockade, metformin for metabolic dysfunction, anti-androgens (spironolactone, finasteride) for hirsutism/acne, fertility treatment (letrozole, clomiphene, gonadotropins, IVF)), endometriosis diagnosis (clinical presentation (dysmenorrhea, dyspareunia, dyschezia, dysuria, chronic pelvic pain), surgical diagnosis via laparoscopy with biopsy) and management (NSAIDs, hormonal suppression (combined oral contraceptives, progestins, GnRH agonists (leuprolide) with add-back therapy, GnRH antagonists (elagolix, relugolix), danazol, aromatase inhibitors), surgical excision, hysterectomy), uterine fibroids (leiomyomas) classification (FIGO classification system), symptoms (heavy menstrual bleeding, bulk symptoms, reproductive dysfunction), management (watchful waiting, medical therapy (NSAIDs, tranexamic acid, GnRH agonists, oral contraceptives, progestin-releasing IUD, elagolix/relugolix combination), minimally invasive procedures (uterine artery embolization (UAE), radiofrequency ablation (Acessa, Sonata), MRI-guided focused ultrasound), surgical options (myomectomy (abdominal, laparoscopic, robotic, hysteroscopic), hysterectomy)), ovarian cysts (functional cysts (follicular cysts, corpus luteum cysts) management (observation, oral contraceptives), pathologic cysts (dermoid/mature cystic teratoma, cystadenoma (serous/mucinous), endometrioma, malignancy), complications (ovarian torsion (surgical emergency, oophorectomy/oophoropexy), rupture, hemorrhage), menopause and perimenopause management (stages of reproductive aging (STRAW+10 criteria), menopause transition symptoms (vasomotor symptoms (hot flashes, night sweats), genitourinary syndrome of menopause (GSM), sleep disturbances, mood changes, cognitive complaints), hormone therapy (estrogen therapy (ET) for hysterectomized women, estrogen plus progestogen therapy (EPT) for women with intact uterus, dosing (standard vs low dose), routes (oral, transdermal patch/gel/emulsion/spray, vaginal ring/cream/tablet), risks and benefits (WHI study findings), non-hormonal pharmacologic options for vasomotor symptoms (SSRIs (paroxetine, escitalopram, citalopram), SNRIs (venlafaxine, desvenlafaxine), gabapentin, pregabalin, clonidine), management of GSM (vaginal moisturizers, lubricants, vaginal estrogen (cream, ring, tablet), vaginal DHEA (prasterone), oral ospemifene), bone health (osteoporosis screening (DXA scan, FRAX tool), prevention and treatment (calcium, vitamin D, bisphosphonates (alendronate, risedronate, zoledronic acid, ibandronate), denosumab, raloxifene, teriparatide, abaloparatide)), reproductive health in special populations (adolescent reproductive health (confidentiality, consent, contraception access, STI screening, HPV vaccination, menstrual disorders), LGBTQ+ health (transgender care (gender-affirming hormone therapy (estrogen/testosterone), fertility preservation, sexual health screening, cervical cancer screening in transgender men, breast cancer screening in transgender women), women with disabilities (access to care, reproductive autonomy, contraception, pregnancy care), survivors of intimate partner violence (IPV) and sexual trauma (trauma-informed care, screening (HARK, HUM, PVS), safety planning, resources), ethical and legal issues (informed consent for contraception and procedures, confidentiality (minor consent laws, Title X), mandatory reporting (child abuse, elder abuse, reportable diseases), reproductive rights (contraception access, abortion access following Dobbs decision), cultural competence in reproductive health, shared decision-making, health literacy, motivational interviewing, and evidence-based clinical guidelines from ACOG (American College of Obstetricians and Gynecologists), ASRM (American Society for Reproductive Medicine), CDC (Centers for Disease Control and Prevention) STI Treatment Guidelines, USPSTF (U.S. Preventive Services Task Force), WHO (World Health Organization), and the Endocrine Society, each answer includes detailed clinical rationales to reinforce advanced practice nursing skills in reproductive health care. Perfect for WHNP, FNP, and advanced practice nursing students preparing for the NRNP 6552 Week 6 Midterm Exam at Walden University. With our Pass Guarantee, you can confidently prepare for your Advanced Reproductive Health Care exam. Download your complete NRNP 6552 Week 6 Midterm Exam with 100 questions and verified answers instantly!